423 related articles for article (PubMed ID: 11835903)
1. The role of the renin-angiotensin system in the development of cardiovascular disease.
Unger T
Am J Cardiol; 2002 Jan; 89(2A):3A-9A; discussion 10A. PubMed ID: 11835903
[TBL] [Abstract][Full Text] [Related]
2. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
3. Neurohormonal modulation in cardiovascular disease.
Unger T
Am Heart J; 2000 Jan; 139(1 Pt 2):S2-8. PubMed ID: 10618581
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
5. [Pathophysiological mechanisms of the renin-angiotensin system and its pharmacologic modification by ACE inhibitors or angiotensin II (type 1) receptor blockers in cardiovascular diseases].
Huber K; Pachinger O; Pichler M; Klein W
Z Kardiol; 1997 Apr; 86(4):239-50. PubMed ID: 9235795
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
7. [Renin-angiotensin system and vascular remodelling].
Michel JB
Med Sci (Paris); 2004 Apr; 20(4):409-13. PubMed ID: 15124112
[TBL] [Abstract][Full Text] [Related]
8. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review.
Dahlöf B
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480
[TBL] [Abstract][Full Text] [Related]
9. The renin-angiotensin-aldosterone system: a specific target for hypertension management.
Weir MR; Dzau VJ
Am J Hypertens; 1999 Dec; 12(12 Pt 3):205S-213S. PubMed ID: 10619573
[TBL] [Abstract][Full Text] [Related]
10. Anti-ischemic potential of drugs related to the renin-angiotensin system.
Ertl G; Hu K
J Cardiovasc Pharmacol; 2001 Apr; 37 Suppl 1():S11-20. PubMed ID: 11392474
[TBL] [Abstract][Full Text] [Related]
11. Spectrum of use for the angiotensin-receptor blocking drugs.
Fabiani ME; Johnston CI
Curr Hypertens Rep; 1999 Oct; 1(5):394-401. PubMed ID: 10981096
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of renin inhibitors in the management of cardiovascular disorders.
Stanton A
Am J Cardiovasc Drugs; 2003; 3(6):389-94. PubMed ID: 14728059
[TBL] [Abstract][Full Text] [Related]
13. ACE-inhibitor, AT1-receptor-antagonist, or both? A clinical pharmacologist's perspective after publication of the results of ONTARGET.
Schindler C
Ther Adv Cardiovasc Dis; 2008 Aug; 2(4):233-48. PubMed ID: 19124424
[TBL] [Abstract][Full Text] [Related]
14. Use of angiotensin II receptor blockers in animal models of atherosclerosis.
Ferrario CM
Am J Hypertens; 2002 Jan; 15(1 Pt 2):9S-13S. PubMed ID: 11824874
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II type 1 receptor blockade: a new development in cardiovascular pharmacology.
Leary AC; MacDonald TM
Int J Clin Pract; 1998 Oct; 52(7):475-81. PubMed ID: 10622089
[TBL] [Abstract][Full Text] [Related]
16. Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension.
Weber MA
Am J Hypertens; 1999 Dec; 12(12 Pt 3):189S-194S. PubMed ID: 10619571
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence.
Unger T; Culman J; Gohlke P
J Hypertens Suppl; 1998 Sep; 16(7):S3-9. PubMed ID: 9855025
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptors in the cardiovascular system.
Wagenaar LJ; Voors AA; Buikema H; van Gilst WH
Can J Cardiol; 2002 Dec; 18(12):1331-9. PubMed ID: 12518185
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin system: genes to bedside.
Malik FS; Lavie CJ; Mehra MR; Milani RV; Re RN
Am Heart J; 1997 Sep; 134(3):514-26. PubMed ID: 9327710
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology of ACE inhibitors versus AT1 blockers.
Vaughan D
Can J Cardiol; 2000 Aug; 16 Suppl E():36E-40E. PubMed ID: 10906625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
